{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:19:26Z","timestamp":1747196366533,"version":"3.40.5"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CureVac SE"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>We assessed the seroepidemiology of SARS-CoV-2 infection and the incidence of coronavirus disease 2019 (COVID-19) before and during the rollout of COVID-19 vaccines, in a prospective observational cohort study on healthcare workers (HCWs) in a large tertiary hospital in Mainz, Germany. Antibody status was assessed during six visits between September 2020 and February 2022. Self-reported symptoms were collected using a smartphone application; symptomatic HCWs were tested using real-time polymerase chain reaction (RT-PCR) assays for SARS-CoV-2. Rates of virologically confirmed and severe COVID-19 were estimated using the U.S. Food and Drug Administration (FDA) and Coalition for Epidemic Preparedness Innovations (CEPI) case definitions, respectively, and were contrasted to background community transmission and circulating SARS-CoV-2 variants. A total of 3665 HCWs were enrolled (mean follow-up time: 18 months); 97 met the FDA definition of virologically confirmed COVID-19 (incidence rate (IR) 2.3\/1000 person-months (PMs), one severe case). Most cases reported \u22652 symptoms, commonly, cough and anosmia or ageusia. Overall, 263 individuals seroconverted (IR 6.6\/1000 PMs\u20142.9 times the estimated IR of COVID-19), indicating many cases were missed, either due to asymptomatic infections or to an atypical presentation of symptoms. A triphasic trend in anti-SARS-CoV-2 seroprevalence and seroconversion was observed, with an initial increase following the rollout of COVID-19 vaccines, a two-fold decline six months later, and finally a six-fold increase by the end of the study when Omicron was the dominant circulating variant. Despite the increase in infection rates at the end of the study due to the circulation of the Omicron variant, the infection and disease rates observed were lower than the published estimates in HCWs and rates in the general local population. Preferential vaccination of HCWs and the strict monitoring program for SARS-CoV-2 infection are the most likely reasons for the successful control of COVID-19 in this high-risk population.<\/jats:p>","DOI":"10.1371\/journal.pone.0294025","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:29:11Z","timestamp":1706639351000},"page":"e0294025","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9755-9155","authenticated-orcid":true,"given":"Stephan","family":"Gehring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Kowalzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Okasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Engelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0577-1624","authenticated-orcid":true,"given":"Christian","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7082-3745","authenticated-orcid":true,"given":"Aline","family":"M\u00e4hringer-Kunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-795X","authenticated-orcid":true,"given":"Wendy","family":"Hartig-Merkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2336-8302","authenticated-orcid":true,"given":"Thao","family":"Mai Phuong Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Oostvogels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Verstraeten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"issue":"8","key":"pone.0294025.ref001","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"N Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0294025.ref002","unstructured":"The World Health Organization [Internet]. Coronavirus disease 2019 (COVID-19) Situation Reports 11, 22, and 52. 2020 [cited 2022 Oct 25]. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports"},{"year":"2021","author":"The World Health Organization [Internet].","key":"pone.0294025.ref003"},{"article-title":"Tracking SARS-CoV-2 variants.","year":"2022","author":"The World Health Organisation [Internet].","key":"pone.0294025.ref004"},{"key":"pone.0294025.ref005","doi-asserted-by":"crossref","first-page":"775224","DOI":"10.3389\/fpubh.2021.775224","article-title":"The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern.","volume":"9","author":"L Lin","year":"2021","journal-title":"Front Public Health"},{"issue":"10332","key":"pone.0294025.ref006","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"T Nyberg","year":"2022","journal-title":"Lancet"},{"key":"pone.0294025.ref007","unstructured":"Robert Koch-Institut: COVID-19-Dashboard 2022 [Internet]. 2022 [cited 2022 Oct 25]. Available from: https:\/\/experience.arcgis.com\/experience\/478220a4c454480e823b17327b2bf1d4"},{"issue":"4","key":"pone.0294025.ref008","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41562-021-01079-8","article-title":"A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker).","volume":"5","author":"T Hale","year":"2021","journal-title":"Nat Hum Behav"},{"article-title":"Therapeutics and COVID-19: Living guideline, 13 January 2023 [Internet].","year":"2023","author":"World Health Organisation","key":"pone.0294025.ref009"},{"key":"pone.0294025.ref010","doi-asserted-by":"crossref","first-page":"820544","DOI":"10.3389\/fmed.2022.820544","article-title":"Real-Word Effectiveness of Global COVID-19 Vaccines Against SARS-CoV-2 Variants: A Systematic Review and Meta-Analysis.","volume":"9","author":"K Wang","year":"2022","journal-title":"Front Med (Lausanne)."},{"article-title":"Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines (17 June 2022).","year":"2022","author":"World Health Organisation [Internet].","key":"pone.0294025.ref011"},{"article-title":"COVID-19 Vaccine Tracker.","year":"2022","author":"VIPER Group COVID-19 Vaccine Tracker Team [Internet].","key":"pone.0294025.ref012"},{"article-title":"COVID-19 vaccines tracker","year":"2022","author":"German Ministry of Health [Internet].","key":"pone.0294025.ref013"},{"key":"pone.0294025.ref014","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"J Yang","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"2","key":"pone.0294025.ref015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/jmv.26427","article-title":"Risk and protective factors of SARS-CoV-2 infection","volume":"93","author":"H Takagi","year":"2021","journal-title":"J Med Virol"},{"issue":"5","key":"pone.0294025.ref016","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.dsx.2020.07.054","article-title":"Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection.","volume":"14","author":"TI Hariyanto","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"pone.0294025.ref017","doi-asserted-by":"crossref","first-page":"104363","DOI":"10.1016\/j.jcv.2020.104363","article-title":"Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China.","volume":"127","author":"R Li","year":"2020","journal-title":"J Clin Virol"},{"issue":"2","key":"pone.0294025.ref018","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaci.2020.06.001","article-title":"Association of asthma and its genetic predisposition with the risk of severe COVID-19","volume":"146","author":"Z Zhu","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"16","key":"pone.0294025.ref019","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.","volume":"323","author":"M Arentz","year":"2020","journal-title":"JAMA"},{"key":"pone.0294025.ref020","first-page":"370","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","author":"Q Zhang","year":"2020","journal-title":"Science"},{"issue":"(3","key":"pone.0294025.ref021","article-title":"Potential Interaction Between SARS-CoV-2 and Thyroid: A Review","volume":"162","author":"W Chen","year":"2021","journal-title":"Endocrinology"},{"key":"pone.0294025.ref022","doi-asserted-by":"crossref","first-page":"104562","DOI":"10.1016\/j.cellimm.2022.104562","article-title":"Immune system changes in those with hypertension when infected with SARS-CoV-2","volume":"378","author":"S Su","year":"2022","journal-title":"Cell Immunol"},{"issue":"9","key":"pone.0294025.ref023","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/S2468-2667(20)30164-X","article-title":"Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study","volume":"5","author":"LH Nguyen","year":"2020","journal-title":"Lancet Public Health"},{"issue":"12","key":"pone.0294025.ref024","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S1473-3099(20)30589-2","article-title":"Risk of COVID-19 in health-care workers in Denmark: an observational cohort study","volume":"20","author":"K Iversen","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pone.0294025.ref025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/aje\/kwaa191","article-title":"COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes","volume":"190","author":"SA Gomez-Ochoa","year":"2021","journal-title":"Am J Epidemiol"},{"issue":"3","key":"pone.0294025.ref026","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.3.2002047","article-title":"Attitudes of healthcare workers towards COVID-19 vaccination: a survey in France and French-speaking parts of Belgium and Canada, 2020","volume":"26","author":"P Verger","year":"2021","journal-title":"Euro Surveill"},{"issue":"4","key":"pone.0294025.ref027","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"CJ Clopper","year":"1934","journal-title":"Biometrika"},{"issue":"5","key":"pone.0294025.ref028","first-page":"791","volume":"58","author":"N Speybroeck","year":"2013","journal-title":"Misclassification errors in prevalence estimation: Bayesian handling with care. International journal of public health"},{"issue":"3\u20134","key":"pone.0294025.ref029","first-page":"437","article-title":"Fiducial limits for the Poisson distribution","volume":"28","author":"F. Garwood","year":"1936","journal-title":"Biometrika"},{"year":"2020","author":"RStudio Team","key":"pone.0294025.ref030"},{"key":"pone.0294025.ref031","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jhin.2020.11.008","article-title":"Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.","volume":"108","author":"P Galanis","year":"2021","journal-title":"J Hosp Infect"},{"key":"pone.0294025.ref032","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijid.2020.10.026","article-title":"Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital","volume":"102","author":"J Herzberg","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"Suppl 3","key":"pone.0294025.ref033","first-page":"139","article-title":"SARS-CoV-2 antibodies in ICU and clinic staff: From Germany\u2019s region with the highest infection rate","volume":"115","author":"T Finkenzeller","year":"2020","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"7","key":"pone.0294025.ref034","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1002\/jmv.27688","article-title":"Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review","volume":"94","author":"KI Notarte","year":"2022","journal-title":"J Med Virol"},{"issue":"24","key":"pone.0294025.ref035","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months","volume":"385","author":"EG Levin","year":"2021","journal-title":"N Engl J Med"},{"issue":"8","key":"pone.0294025.ref036","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.vaccine.2021.11.061","article-title":"COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales","volume":"40","author":"S Bedston","year":"2022","journal-title":"Vaccine"},{"issue":"5","key":"pone.0294025.ref037","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.vaccine.2021.12.032","article-title":"Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020\u2014October 2021","volume":"40","author":"E Poukka","year":"2022","journal-title":"Vaccine"},{"issue":"10328","key":"pone.0294025.ref038","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"DR Feikin","year":"2022","journal-title":"Lancet"},{"key":"pone.0294025.ref039","article-title":"SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection","author":"S Cele","year":"2021","journal-title":"medRxiv"},{"issue":"16","key":"pone.0294025.ref040","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant","volume":"386","author":"N Andrews","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0294025.ref041","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.52225\/narra.v2i3.88","article-title":"The race for clinical trials on Omicron-based COVID-19 vaccine candidates: Updates from global databases","volume":"2","author":"SG Viveiros-Rosa","year":"2022","journal-title":"Narra J"},{"issue":"1","key":"pone.0294025.ref042","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1038\/s41467-020-18848-0","article-title":"SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden.","volume":"11","author":"AS Rudberg","year":"2020","journal-title":"Nat Commun"},{"issue":"10335","key":"pone.0294025.ref043","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study","volume":"399","author":"C Menni","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"pone.0294025.ref044","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/jmv.27457","article-title":"Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis","volume":"94","author":"S Chandan","year":"2022","journal-title":"J Med Virol"},{"key":"pone.0294025.ref045","unstructured":"European Centre for Disease Prevention and Control [Internet]. COVID-19 vaccines tracker [cited 2022 Oct 25]. Available from: https:\/\/vaccinetracker.ecdc.europa.eu\/public\/extensions\/covid-19\/vaccine-tracker.html#uptake-tab"},{"key":"pone.0294025.ref046","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijid.2021.01.013","article-title":"COVID-19 and healthcare workers: A systematic review and meta-analysis","volume":"104","author":"M Gholami","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"12","key":"pone.0294025.ref047","doi-asserted-by":"crossref","first-page":"e2137257","DOI":"10.1001\/jamanetworkopen.2021.37257","article-title":"Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis","volume":"4","author":"Q Ma","year":"2021","journal-title":"JAMA Network Open"},{"issue":"1","key":"pone.0294025.ref048","doi-asserted-by":"crossref","first-page":"e0245001","DOI":"10.1371\/journal.pone.0245001","article-title":"Impact of SARS-CoV-2 pandemic among health care workers in a secondary teaching hospital in Spain.","volume":"16","author":"J Garralda Fernandez","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"pone.0294025.ref049","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eimc.2020.11.015","article-title":"Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital.","volume":"40","author":"MI Gal\u00e1n","year":"2020","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"6","key":"pone.0294025.ref050","doi-asserted-by":"crossref","first-page":"e050824","DOI":"10.1136\/bmjopen-2021-050824","article-title":"Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort study","volume":"11","author":"L Mortgat","year":"2021","journal-title":"BMJ Open"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0294025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:29:39Z","timestamp":1706639379000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0294025"}},"subtitle":[],"editor":[{"given":"Harapan","family":"Harapan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0294025","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,1,30]]}}}